CEBPA and acute myeloid leukemia: To validate our findings and to test if a similar activity is present in human AML patients with C/EBPα mutations, we compared human AML-blast cells containing the C/EBPα-K313 mutation with AML-blast cells with wt C/EBPα (Table S1).